IndiaOne Finance - Company Dashboard

Governance Classic Home

Shukra Pharmaceuticals LtdPharmaceuticalsINE551C01044

Valuation

Market Cap₹2.46K Cr

TTM PE68.24x

Forward PE54.51x

PEG0.96

Book Value₹11.47

P/B4.88x

TTM EPS₹0.82

Fwd EPS₹1.03

TTM Revenue₹74.84 Cr

TTM PAT₹36.05 Cr

TTM EBITDA₹48.62 Cr

TTM EBIT₹44.89 Cr

Last Qtr PAT₹-1.73 Cr

Last Qtr EBITDA₹21.20 Cr

Last Qtr EBIT₹20.13 Cr

Profitability

ROE—

ROCE—

TTM NPM48.17%

TTM EBITDA %64.97%

Curr OPM63.89%

Last OPM-27.40%

Curr NPM—

Last NPM—

Curr EPS₹0.34

Last EPS₹-0.04

Balance sheet

Equity—

Reserve—

Total Debt₹0.00 Cr

D/E—

Interest %2.86%

Curr Interest₹0.43 Cr

Price / range

Close₹55.96

vs 52W High-3.25%

vs 52W Low+112.78%

MA50—

MA200—

Returns

1D+3.13%

1W+3.74%

1M+34.23%

3M+83.84%

6M+76.03%

1Y+76.03%

2Y+788.25%

3Y+1124.51%

5Y+2564.76%

Diwali+322.98%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	148.17	3.58%
DIVISLAB	9375.00	₹2.49L Cr	84.62	17.55%
TORNTPHARM	4840.00	₹1.84L Cr	78.80	25.43%
ZYDUSLIFE	1160.00	₹1.16L Cr	33.21	12.96%
CIPLA	1394.50	₹1.13L Cr	36.64	8.93%
LAURUSLABS	1954.00	₹1.06L Cr	120.92	16.46%
AUROPHARMA	1734.00	₹99.77K Cr	38.79	6.84%
DRREDDY	1185.00	₹98.91K Cr	148.68	1.75%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	23.52+336.4%	6.30	39.14	5.88	5.39	56.71
Other Income	0.54	0.95	0.82	1.71	1.11	4.59
Total Income	24.06+270.2%	7.25	39.95	7.59	6.50	61.29
Interest	0.43	0.26	0.28	0.29	0.27	1.09
Expenditure	-3.82+25.1%	-6.88	-13.12	-7.39	-5.10	-32.52
PBDT	0	0	0	0	0	0
EBITDA	21.20+1470.4%	0.69	27.14	-0.41	1.35	28.72
Depreciation	-1.07	-1.01	-0.84	-0.81	-0.79	-3.44
EBIT	20.13+3494.6%	-0.32	26.30	-1.22	0.56	25.28
PBT	20.24+1377.4%	0.37	26.83	0.20	1.37	28.77
Tax	-5.21	-2.09	-4.85	2.18	-0.30	-5.10
Equity	0	0	0	0	0	0
OPM	86.06	5.84	68.56	3.39	25.47	47.00
Net Profit	15.03+1359.2%	-1.73	20.37	2.38	1.03	22.05
NPM	63.89	-27.40	52.04	40.46	19.11	36.00
EPS	0.34	-0.04	0.47	0.05	0	0.50

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	56.71+74.0%	32.59-56.3%	74.57+26.8%	58.83+187.1%	20.49+82.9%	11.20
Other Income	4.59	4.21	2.82	1.20	0.08	0.36
Total Income	61.29+66.6%	36.79-52.5%	77.39+28.9%	60.03+191.8%	20.57+78.1%	11.55
Expenditure	-32.52-39.0%	-23.40+59.3%	-57.51-3.5%	-55.59-184.3%	-19.55-73.6%	-11.26
Interest	-1.09	-0.60	-0.29	-0.28	-0.29	-0.03
PBDT	0	0	0	0	0	0
EBITDA	28.72+124.4%	12.80-34.0%	19.40+261.9%	5.36+85.5%	2.89+100.7%	1.44
Depreciation	-3.44	-3.01	-2.05	-1.84	-1.66	-1.47
EBIT	25.28+158.2%	9.79-43.6%	17.35+392.9%	3.52+186.2%	1.23+4200.0%	-0.03
PBT	28.77+115.7%	13.34-32.9%	19.88+347.7%	4.44+335.3%	1.02+920.0%	0.10
Tax	-5.10	-3.70	-1.35	-0.04	-0.27	-0.06
Equity	0	0	0	0	0	0
OPM (%)	47.00	36.00	26.00	7.00	5.00	1.00
Net Profit	22.05+130.2%	9.58-48.3%	18.54+320.4%	4.41+488.0%	0.75+2400.0%	0.03
NPM (%)	36.00	26.00	24.00	7.00	4.00	0.00
EPS (Rs)	0.50+127.3%	0.22-98.7%	16.93-35.4%	26.21+447.2%	4.79+2077.3%	0.22
CEPS	0.50	0.22	16.93	26.21	4.79	0.22

Metric	Dec-25
Revenue	39.14
Other Income	0.82
Total Income	39.95
Interest	0.28
Expenditure	-13.12
PBDT	0
EBITDA	27.14
Depreciation	-0.84
EBIT	26.30
PBT	26.83
Tax	-4.85
Equity	0
OPM	67.16
Net Profit	20.37
NPM	50.98
EPS	0.47

Yearly results

Last 6 financial years · YoY % vs previous FY

No yearly result data.

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2025	Final Dividend	0.01	18 Sep 2025
2024	Final Dividend	1	23 Sep 2024
2023	Final Dividend	0.5	15 Sep 2023
2022	Final Dividend	0.5	22 Sep 2022
2019	Final Dividend	0.5	19 Sep 2019
2018	Final Dividend	0.5	31 Aug 2018

Bonus

Year	Ratio	Ex-Date
2024	3:1	19 Apr 2024

Split

Year	Ratio	Ex-Date
2025	Rs.10/- to Rs.1/-	21 Mar 2025

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split